ES2108693T3 - Compuestos y tratamientos para la neumonia en animales. - Google Patents

Compuestos y tratamientos para la neumonia en animales.

Info

Publication number
ES2108693T3
ES2108693T3 ES90906831T ES90906831T ES2108693T3 ES 2108693 T3 ES2108693 T3 ES 2108693T3 ES 90906831 T ES90906831 T ES 90906831T ES 90906831 T ES90906831 T ES 90906831T ES 2108693 T3 ES2108693 T3 ES 2108693T3
Authority
ES
Spain
Prior art keywords
haemolytica
pneumonia
antigens
well
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90906831T
Other languages
English (en)
Inventor
Stephen D Acres
Lorne A Bariuk
Andrew A Potter
Michael J P Lawman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Saskatchewan
Original Assignee
University of Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Saskatchewan filed Critical University of Saskatchewan
Application granted granted Critical
Publication of ES2108693T3 publication Critical patent/ES2108693T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBEN PROTEINAS Y ANTIGENOS DE SUBUNIDADES NUEVOS A PARTIR DE LA P. HAEMOLYTICA PARA SU EMPLEO EN LA ESTIMULACION DE LA INMUNIDAD CONTRA ENFERMEDADES RESPIRATORIAS TALES COMO LA NEUMONIA, ENTRE ELLAS LA NEUMONIA DE LA FIEBRE DEL EMBARQUE. LOS ANTIGENOS DE SUBUNIDADES INCLUYEN SECUENCIAS DE AMINOACIDOS INMUNOGENICOS DE LA PROTEINA FIMBRIAL DE P. HAEMOLYTICA, DE LA PROTEINA DEL RECEPTOR PLASMIDO DE P. HAEMOLYTICA Y DE LA PROTEINA DE LA MEMBRANA EXTERIOR 50 K DE P. HAEMOLYTICA Y DE LA LEUCOTOXINA DE P. HAEMOLYTICA. LOS ANTIGENOS SE PUEDEN UTILIZAR EN UNA COMPOSICION PARA UNA VACUNA, BIEN SOLOS BIEN COMBINADOS. TAMBIEN SE DESCRIBEN METODOS DE VACUNACION ASI COMO METODOS DE FABRICACION DE LOS ANTIGENOS DE SUBUNIDADES EMPLEADOS EN LAS VACUNAS.
ES90906831T 1990-04-05 1990-05-25 Compuestos y tratamientos para la neumonia en animales. Expired - Lifetime ES2108693T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50485090A 1990-04-05 1990-04-05

Publications (1)

Publication Number Publication Date
ES2108693T3 true ES2108693T3 (es) 1998-01-01

Family

ID=24008001

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90906831T Expired - Lifetime ES2108693T3 (es) 1990-04-05 1990-05-25 Compuestos y tratamientos para la neumonia en animales.

Country Status (8)

Country Link
EP (1) EP0527724B1 (es)
JP (1) JPH05508301A (es)
AT (1) ATE157258T1 (es)
AU (1) AU642650B2 (es)
DE (1) DE69031351T2 (es)
ES (1) ES2108693T3 (es)
FI (1) FI924457A7 (es)
WO (1) WO1991015237A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849531A (en) * 1989-04-07 1998-12-15 University Of Saskatchewan Compositions and treatments for pneumonia in animals
CA2014033C (en) * 1989-04-07 1993-02-09 Stephen D. Acres Compositions and treatments for pneumonia in animals
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
US6797272B1 (en) 1991-10-16 2004-09-28 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
AU2699192A (en) * 1991-10-16 1993-05-21 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5422110A (en) * 1991-10-16 1995-06-06 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
MX9301736A (es) * 1992-03-30 1994-01-31 Smithkline Beecham Corp Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
US5534256A (en) * 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
US5441736A (en) * 1992-11-05 1995-08-15 University Of Saskatchewan Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof
AU1860095A (en) * 1994-03-22 1995-10-09 Pfizer Inc. (pasteurellaceae) antigens and related vaccines
EP1060249A1 (en) * 1998-03-02 2000-12-20 The Government of the United States represented by the Secretary of the Department of Health and Human Services Epitope peptides immunogenic against streptococcus pneumoniae
US6903184B1 (en) 1998-03-02 2005-06-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Multiple antigenic peptides immunogenic against Streptococcus pneumonia
US20100330158A1 (en) * 2009-03-31 2010-12-30 Innopharma, Llc Protein-assisted drug delivery system for the targeted administration of active agents
WO2010115278A1 (en) * 2009-04-06 2010-10-14 University Of Saskatchewan Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection

Also Published As

Publication number Publication date
JPH05508301A (ja) 1993-11-25
WO1991015237A1 (en) 1991-10-17
DE69031351D1 (de) 1997-10-02
EP0527724A1 (en) 1993-02-24
EP0527724B1 (en) 1997-08-27
AU642650B2 (en) 1993-10-28
DE69031351T2 (de) 1998-02-05
AU5662190A (en) 1991-10-30
FI924457L (fi) 1992-10-02
FI924457A0 (fi) 1992-10-02
ATE157258T1 (de) 1997-09-15
FI924457A7 (fi) 1992-10-02

Similar Documents

Publication Publication Date Title
ES2063965T3 (es) Vacunas para haemophilus influenzae no tipificable.
BR0108566A (pt) Método para a regulação negativa in vivo de proteìna amilóide em um animal, incluindo um ser humano e para o tratamento e/ou prevenção e/ou melhora da doença de alzheimer ou outras doenças e condições cartacterizadas por depósitos de amilóide, análogo de um polipeptìdeo amiloidogênico,composição imunogênica, fragmento de ácido nucleico, vetor, célula transformada, composição para induzir a produção de anticorpos contra um polipeptìdeo amiloidogênico, linhagem celular estável, métodos para a preparação de uma célula, para a identificação de um polipeptìdeo amiloidogênico modificado, e para preparação de uma composição imunogênica, uso de um polipeptìdeo amiloidogênico ou de uma subsequência do mesmo, e, uso de um análogo de um polipeptìdeo amiloidogênico
Nobiron et al. Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice
RU2005127200A (ru) Менингококковые вакцины для введения через слизистую оболочку
DE68921895D1 (de) Meningococcales klasse i-aussenmembranprotein-vakzin.
TWI329130B (en) Functionally reconstituted viral membranes containing adjuvant
FI924457A0 (fi) Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
BR1101088A (pt) Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura
AR035586A1 (es) Composicion de vacuna, equipo, metodos para incrementar la respuesta inmune, uso de un derivado de 1h-imidazo(4,5-c)quinolin-4-amina en la fabricacion de un medicamento, y combinacion de componentes para la administracion separada, secuencial o concomitante para el uso en la vacunacion de adn
HUP9901254A2 (hu) Nemdendrites szerkezetű gerincet alkotó peptid hordozó
AU4951196A (en) Vaccines for plague
RU2010138815A (ru) МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHBP
ES2180758T3 (es) Vacunas de pertussis acelulares y metodos de preparacion de las mismas.
GB2255093A (en) Hiv-1 core protein fragments
DE69930630D1 (de) B2microglobulin fusionsproteine und varianten mit hoher affinität
ES2334185T3 (es) Proteina psaa lipidada recombinante, procedimientos de preparacion y uilizacion.
ES2050435T3 (es) Una preparacion medicinal o vacuna y composicion inmunogenica peptida, un metodo de inmunizacion de un mamifero contra lhrh, y un metodo para mejorar la calidad carnica del ganado porcuno.
DE69828801D1 (de) Peptide abgeleitet vom bindungs (g) protein des respiratorisches synzytialvirus
GB2220939B (en) Peptide fragments of hiv and their use in vaccines and diagnosis
FI902569A0 (fi) Producering av till gonorre anslutande pi-proteiner och vaccin.
ES2051909T3 (es) Vacuna del conjugado de polisacarido-proteina de membrana externa contra la haemophilus influenzae tipo b.
CN102488898B (zh) 龋齿疫苗及制备方法
CN109069424A (zh) 脂质体疫苗
AR053661A1 (es) Peptido para entregar vacunas via mucosas
ES2549669T3 (es) Propiedades de coadyuvancia y potenciación inmunitaria de productos naturales de Onchocerca volvulus

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 527724

Country of ref document: ES